These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10862263)

  • 1. Conjugated estrogens--the natural SERMs.
    Gruber DM; Huber JC
    Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():9-12. PubMed ID: 10862263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?].
    Lippert TH; Seeger H; Mueck AO
    Dtsch Med Wochenschr; 1999 Oct; 124(42):1245-8. PubMed ID: 10572534
    [No Abstract]   [Full Text] [Related]  

  • 7. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
    Bhavnani BR
    Proc Soc Exp Biol Med; 1998 Jan; 217(1):6-16. PubMed ID: 9421201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Romero M
    Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
    [No Abstract]   [Full Text] [Related]  

  • 11. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
    Walsh BW
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of bone mineral density during estrogen replacement therapy.
    Thijssen JH; Druckmann R
    Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():29-34. PubMed ID: 10862266
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women.
    Shifren JL; Desindes S; McIlwain M; Doros G; Mazer NA
    Menopause; 2007; 14(6):985-94. PubMed ID: 17507833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17 beta-estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanism.
    Viganò G; Zoja C; Corna D; Rossini M; Pusineri F; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1990 Jan; 252(1):344-8. PubMed ID: 2153805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
    Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
    Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.